Atlas Trials

TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT04891900 · UNKNOWN

Trial details

NCT number
NCT04891900
Sponsor
Henan Cancer Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Gastric CancerAdenocarcinoma of Esophagogastric Junction
Start date
2021-05-10
Primary completion
2024-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.